Country: Малезија
Језик: Енглески
Извор: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
MEFENAMIC ACID
PFIZER (MALAYSIA) SDN. BHD.
MEFENAMIC ACID
500Tablet Tablets
Pt. Pfizer Indonesia
Pfizer Confidential _CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP)_ PONSTAN ® TABLET Mefenamic Acid (500 mg) PLD Title : Mefenamic Acid (PONSTAN) PLD Date : 25 September 2020 Country : Malaysia Reference Document : Malaysia CLD dated 20 January 2020 Reason for change : PfLEET Number 2020-0060076 (S2) - To update as per new effective CLD dated 20 January 2020 : To update serial number Pfizer Confidential _CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP)_ PONSTAN ® TABLET Mefenamic Acid (500 mg) 1 WHAT IS IN THIS LEAFLET 1. What Ponstan is used for 2. How Ponstan works 3. Before you use Ponstan 4. How to use Ponstan 5. While you are using it 6. Side effects 7. Storage and Disposal of Ponstan 8. Product Description 9. Manufacturer and Product Registration Holder 10. Date of Revision 11. Serial Number WHAT PONSTAN IS USED FOR Ponstan is used to relieve: Pain due to rheumatoid arthritis including Still's Disease, Pain due to osteoarthritis, Muscle pain, Trauma-related pain, Pain after injury, Toothaches, Headaches, Pain following an operation, Pain after childbirth, Painful menstruation (dysmenorrhea), Fever in children over 6 months of age. It is used to treat pre-menstrual syndrome and also abnormally heavy bleeding due to dysfunctional causes or the presence of an intrauterine device (IUD) HOW PONSTAN WORKS Ponstan contains the active substance mefenamic acid which belongs to a group of medicines called non- steroidal anti-inflammatory drugs (NSAIDs). These medicines reduce pain (analgesic) and swelling, (anti- inflammatory) and brings down fever (antipyretic) BEFORE YOU USE PONSTAN - _When you must not use it_ Do not take Ponstan if: - you are allergic (hypersensitive) to mefenamic acid or any of the other ingredients of this medicine; - you show any signs of allergy (such as asthma, hay fever or hives) to aspirin or other NSAIDs. An allergic reaction may include swelling of the face, lips, mouth, tongue or throat which may cause difficulty in swallowing or breath Прочитајте комплетан документ
Pfizer Confidential 1 PONSTAN MEFENAMIC ACID 1.0 NAME OF THE MEDICINAL PRODUCT PONSTAN 2.0 QUALITATIVE AND QUANTITATIVE COMPOSITION Active Ingredient: Mefenamic acid Mefenamic acid is available as: Coated Tablets containing 500 mg mefenamic acid 3.0 PHARMACEUTICAL FORM Elliptical, smooth, yellow film coated tablets, embossed with 'P-D' logo on one side and bisected line on the other side. 4.0 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Mefenamic acid is indicated for: 1) The symptomatic relief of RHEUMATOID ARTHRITIS (including STILL'S DISEASE), OSTEOARTHRITIS, and PAIN including muscular, traumatic and dental pain, headaches of most etiology, post-operative and postpartum pain 2) The symptomatic relief of PRIMARY DYSMENORRHEA 3) MENORRHAGIA due to dysfunctional causes or the presence of an intrauterine device (IUD) when organic pelvic pathology has been excluded 4) Premenstrual syndrome 5) The relief of PYREXIA IN PEDIATRIC PATIENTS OVER 6 MONTHS OF AGE 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Undesirable effects may be minimized by using the minimum effective dose for the shortest duration necessary to control symptoms. The oral dosage form of mefenamic acid may be taken with food if gastrointestinal upset occurs. _Mild to moderate pain/rheumatoid arthritis/osteoarthritis in adults and adolescents _ _over 14 years of age_: 500 mg three times daily. Pfizer Confidential 2 _Dysmenorrhea_: 500 mg three times daily, to be administered at the onset of menstrual pain and continued while symptoms persist according to the judgement of the physician. _Menorrhagia:_ 500 mg three times daily, starting with the onset of bleeding and associated symptoms and continued according to the judgement of the physician. _Premenstrual syndrome_: 500 mg three times daily, starting with the onset of symptoms and continued until the anticipated cessation of symptoms according to the judgement of the physician. _For Still's Disease or antipyretic action in infants and children over 6 months to 14 _ _years:_ 19.5 mg/kg to 25 mg/kg of Прочитајте комплетан документ